Next Article in Journal
Comparison of Radiographic and Patient-Reported Outcomes in Robotic-Assisted Versus Manual Total Knee Arthroplasty Using Medial-Congruent Bearing
Previous Article in Journal
Evaluation of an Elastodontic Bioactivator Versus High-Pull Headgear for the Treatment of Skeletal Class II Hyperdivergent Pediatric Patients: A Retrospective Study
Previous Article in Special Issue
Impact of Pulmonary Rehabilitation on Physical, Mental Health and Quality of Life in Children with Post-COVID-19 Condition: A 12-Month Quasi-Experimental Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Review

An Overview of Severe Myalgic Encephalomyelitis

1
Independent Researcher, 1096 HZ Amsterdam, The Netherlands
2
Independent Researcher, 30159 Hannover, Germany
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2026, 15(2), 805; https://doi.org/10.3390/jcm15020805 (registering DOI)
Submission received: 9 December 2025 / Revised: 29 December 2025 / Accepted: 9 January 2026 / Published: 19 January 2026
(This article belongs to the Special Issue POTS, ME/CFS and Long COVID: Recent Advances and Future Direction)

Abstract

In this article, we have reviewed the literature on severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). ME/CFS is a clinical diagnosis in the absence of a diagnostic test. However, in research settings and disability disputes, 2-day cardiopulmonary exercise testing can be used to diagnose and document the abnormal response to exercise. Biomedical research into this disease has been scarce and underfunded for decades. Consequently, there are no effective treatments. In its most severe form, it is more disabling than many other diseases, and patients are bedbound 24/7, dependent on carers, and spend their days in dark and quiet rooms. Even the soft sound of a human voice can lead to further deterioration. Some of the very severely ill suffer from life-threatening malnutrition and need to be tube-fed. The COVID-19 pandemic has led to a sharp increase in the number of patients with post-infectious diseases, and many of them fulfill ME/CFS criteria. Dedicated, focused research using advanced medical technologies is needed to gain further understanding of the underlying disease mechanism. This will enable us to find effective pharmacological treatments and address the unmet medical needs of these very ill people.
Keywords: CFS; chronic fatigue syndrome; functional gastrointestinal disease; gastroparesis; medical gaslighting; ME/CFS; POTS; severely affected (housebound) patients; (very) severe chronic disease CFS; chronic fatigue syndrome; functional gastrointestinal disease; gastroparesis; medical gaslighting; ME/CFS; POTS; severely affected (housebound) patients; (very) severe chronic disease

Share and Cite

MDPI and ACS Style

Vink, M.; Vink-Niese, A. An Overview of Severe Myalgic Encephalomyelitis. J. Clin. Med. 2026, 15, 805. https://doi.org/10.3390/jcm15020805

AMA Style

Vink M, Vink-Niese A. An Overview of Severe Myalgic Encephalomyelitis. Journal of Clinical Medicine. 2026; 15(2):805. https://doi.org/10.3390/jcm15020805

Chicago/Turabian Style

Vink, Mark, and Alexandra Vink-Niese. 2026. "An Overview of Severe Myalgic Encephalomyelitis" Journal of Clinical Medicine 15, no. 2: 805. https://doi.org/10.3390/jcm15020805

APA Style

Vink, M., & Vink-Niese, A. (2026). An Overview of Severe Myalgic Encephalomyelitis. Journal of Clinical Medicine, 15(2), 805. https://doi.org/10.3390/jcm15020805

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop